234 related articles for article (PubMed ID: 29215498)
1. Postoperative Deep Vein Thrombosis, Pulmonary Embolism, and Myocardial Infarction: Complications After Therapeutic Anticoagulation in the Patient With Spine Trauma.
Shiu B; Le E; Jazini E; Weir TB; Costales T; Caffes N; Paryavi E; O'Hara N; Gelb DE; Koh EY; Ludwig SC
Spine (Phila Pa 1976); 2018 Jul; 43(13):E766-E772. PubMed ID: 29215498
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of initiation of thromboprophylaxis in spine trauma managed operatively: A nationwide propensity-matched analysis of trauma quality improvement program.
Zeeshan M; Khan M; O'Keeffe T; Pollack N; Hamidi M; Kulvatunyou N; Sakran JV; Gries L; Joseph B
J Trauma Acute Care Surg; 2018 Aug; 85(2):387-392. PubMed ID: 29613956
[TBL] [Abstract][Full Text] [Related]
3. Timing and risks of chemoprophylaxis after spinal surgery: a single-center experience with 6869 consecutive patients.
Dhillon ES; Khanna R; Cloney M; Roberts H; Cybulski GR; Koski TR; Smith ZA; Dahdaleh NS
J Neurosurg Spine; 2017 Dec; 27(6):681-693. PubMed ID: 28885127
[TBL] [Abstract][Full Text] [Related]
4. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
6. Operative spinal trauma: Thromboprophylaxis with low molecular weight heparin or a direct oral anticoagulant.
Hamidi M; Zeeshan M; Kulvatunyou N; Mitra HS; Hanna K; Tang A; Northcutt A; O'Keeffe T; Joseph B
J Thromb Haemost; 2019 Jun; 17(6):925-933. PubMed ID: 30924300
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
8. Impact of venous thromboembolism chemoprophylaxis on postoperative hemorrhage following operative stabilization of spine fractures.
Sharpe JP; Gobbell WC; Carter AM; Pahlkotter MK; Muhlbauer MS; Camillo FX; Fabian TC; Croce MA; Magnotti LJ
J Trauma Acute Care Surg; 2017 Dec; 83(6):1108-1113. PubMed ID: 28697027
[TBL] [Abstract][Full Text] [Related]
9. Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.
De León LE; Bravo-Iñiguez CE; Fox S; Tarascio J; Freyaldenhoven S; Lapidot M; Jaklitsch MT; Bueno R
J Thorac Cardiovasc Surg; 2020 Oct; 160(4):1064-1073. PubMed ID: 32113716
[TBL] [Abstract][Full Text] [Related]
10. Safety and comparative efficacy of initiating low-molecular-weight heparin within 24 hours of injury or surgery for venous thromboembolism prophylaxis in patients with spinal cord injury: a prospective TRACK-SCI registry study.
Lui A; Park C; Chryssikos T; Radabaugh H; Patel A; Aabedi AA; Ferguson AR; Torres Espin A; Mummaneni PV; Dhall SS; Duong-Fernandez X; Saigal R; Chou A; Pan J; Singh V; Hemmerle DD; Kyritsis N; Talbott JF; Pascual LU; Huie JR; Whetstone WD; Bresnahan JC; Beattie MS; Weinstein PR; Manley GT; DiGiorgio AM
Neurosurg Focus; 2023 Oct; 55(4):E17. PubMed ID: 37778033
[TBL] [Abstract][Full Text] [Related]
11. The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
Cloney MB; Hopkins B; Dhillon ES; Dahdaleh NS
J Neurosurg Spine; 2018 Jan; 28(1):88-95. PubMed ID: 29125431
[TBL] [Abstract][Full Text] [Related]
12. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
[TBL] [Abstract][Full Text] [Related]
13. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
[TBL] [Abstract][Full Text] [Related]
14. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
18. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
[TBL] [Abstract][Full Text] [Related]
19. Safety and low molecular weight heparin in older people in a hospital with ambulatory care.
Chan DK; Ong B; Almafragy H; Karr M; Hung AW; Liu JG
Arch Gerontol Geriatr; 2006; 43(2):233-41. PubMed ID: 16359739
[TBL] [Abstract][Full Text] [Related]
20. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
Graif A; Kimbiris G; Grilli CJ; Agriantonis DJ; Putnam SG; Leung DA
J Vasc Interv Radiol; 2020 Apr; 31(4):537-543. PubMed ID: 31959518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
